Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Masked, Randomized, One-Year Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle-Control in Subjects With Dry Eye Disease (DED)

NCT02405039 is registered in ClinicalTrials.gov with Eleven Biotherapeutics as lead sponsor.

NCT NCT02405039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02405039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Masked, Randomized, One-Year Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle-Control in Subjects With Dry Eye Disease (DED)
Lead sponsor
Eleven Biotherapeutics
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2015
Completion date
July 31, 2016
Enrollment
188 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye